Abstract:Colon cancer is currently the fourth most common cancer in the United States, impacting over 100,000 people every year with increasingly younger patients affected by the malignancy. As a result, it is imperative to better understand the mechanisms that are involved in the development of colon cancer within the body. The intestine houses the largest compartment of the human body's immune system, and the intestinal immune system has been implicated in the development of disease and malignancy of both the colon itself and other organ systems throughout the body. In particular, the colon contains high numbers of IgA antibodies (produced by B-cells) in conjunction with regulatory T cells (Treg). Because of the colon's rich immune system involvement, we are interested in recapitulating several of the immune components and their roles in both targeting tumors and aiding tumors in their aggression. We strive to develop an accurate model of anti-tumor immune cells (CD8+ T-cells, CD4+ T-cells, Natural Killer Cells, Macrophages, Dendritic Cells, Neutrophils) and immunosuppressive cells (Treg, Myeloid-Derived Suppressor Cells) and their engagement with colon adenocarcinoma. The model is built in a nested fashion, beginning with the parametrization of a model of a monolayer from cell cycle and doubling time data. Growth parameters are subsequently obtained for spheroids with no immune cells, spheroids with immune cells, allograft studies in immunocompromised mice, and allograft studies in mice with intact immune systems. The model further incorporates cell cycle stages, quiescence, necrosis, VEGF and TNF-alpha production, and vascularization of the in vivo tumors. The data used to parametrize our model is obtained from literature centered around experiments with CT26 BALB/c murine colon adenocarcinoma both in vitro and in vivo. This cell line is of particular interest because of the large body of publications that utilize it and because the cells form tumors in both immunocompromised and syngeneic BALB/c mice thereby allowing for parametrization of the in vivo model both with and without immune interaction. There are additionally experimental studies through which spheroids were generated with various immune cell infiltrates, thereby enabling more accurate parametrization of each of the immune populations and their impacts on tumor development. We thus aim to develop a novel ODE model of colon adenocarcinoma and the various immune cells that engage in the tumor microenvironment to better evaluate the impacts of these immune populations and the outcomes of immunotherapy targeted at these cells. Citation Format: Frederika Rentzeperis, Maya Srinivasan, Dorothy Wallace. Mathematical modeling of the tumor-immune microenvironment in murine colon adenocarcinoma [abstract]. In: Proceedings of the AACR Special Conference on the Evolutionary Dynamics in Carcinogenesis and Response to Therapy; 2022 Mar 14-17. Philadelphia (PA): AACR; Cancer Res 2022;82(10 Suppl) nr A037.

A novel approach to control PMSG-based wind energy systems

Differential Requirements for CD4+ T Cells in the Efficacy of the Anti-Pd-1+lag-3 and Anti-Pd-1+ctla-4 Combinations in Melanoma Flank and Brain Metastasis Models.

Tumor Microenvironment-Modulated Multiple Nanotherapeutic System for Potent Cancer Immunotherapy and Metastasis Inhibition

Diagnosis of preterm premature rupture of the membranes using a newly developed AFP monoclonal antibody test kit.

Investigating the synergistic effects of immunotherapy and normalization treatment in modulating tumor microenvironment and enhancing treatment efficacy

Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody

Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells

Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment

Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment

Mathematical Modeling of Tumor Immune Interactions: The Role of Anti-FGFR and Anti-PD-1 in the Combination Therapy

Agent-based modeling of tumor-immune interactions reveals determinants of final tumor states

Immune checkpoint therapy modeling of PD-1/PD-L1 blockades reveals subtle difference in their response dynamics and potential synergy in combination

Data-driven mathematical modeling and quantitative analysis of cell dynamics in the tumor microenvironment

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8 + T Cells During Tumorigenesis

A biomathematical model of tumor response to radioimmunotherapy with $α$PDL1 and $α$CTLA4

Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy

Mathematical Modeling of the Synergetic Effect between Radiotherapy and Immunotherapy

Abstract A037: Mathematical modeling of the tumor-immune microenvironment in murine colon adenocarcinoma

Mathematical modeling of tumor-tumor distant interactions supports a systemic control of tumor growth

A GiD-based implementation of a panel method for sailing yachts flow computation

A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation